Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

ADVANCE Outcomes at ERS 2026 demonstrated improved odds of improvement and reduced odds of worsening.

Ralinepag Improves Clinical Outcomes in Contemporary PAH Population

The investigational therapy did not achieve statistical significance in KCCQ-TSS or in 6MWD, but saw substantial changes in exploratory secondary endpoints.

LEVEL: Levosimendan Fails to Improve Exercise Limitations, Betters NT-proBNP and RVSP

Erin Michos, MD, MHS, explains why hypertension risk rises earlier in women and how aldosterone and menopause drive that risk. 

Sex Hormones, Aldosterone, and Hypertension Risk in Women, With Erin Michos, MD

An individual participant data meta-analysis found antihypertensive therapy reduced cardiovascular events only in patients with at least 80% medication adherence.

Low Adherence Cuts Cardiovascular Benefit of Blood Pressure Therapy

United Therapeutics' ralinepag NDA rests on phase 3 ADVANCE OUTCOMES data showing a 55% reduction in clinical worsening versus placebo.

FDA Accepts NDA for Ralinepag in Pulmonary Arterial Hypertension

John Giacona, PhD, PA-C, discusses building a comprehensive multidisciplinary care team for interstitial lung disease and how APPs should engage with clinical evidence.

Multidisciplinary Care, Evidence-Based Practice in ILD: John Giacona, PhD

John Giacona, PhD, PA-C, discusses the cardiology perspective on screening for and managing pulmonary hypertension in interstitial lung disease.

Cardiology's Role in Identifying Pulmonary Hypertension in ILD

Bryan Wells, MD, breaks down new data from 3 universities that have produced a relatively consistent peak systolic velocity, indicating the potential for broad treatment guidelines.

FMD Peak Systolic Velocity May Lead to Comprehensive Clinical Guidelines

Mohammed Chowdhury, MD, a Temple University cardiologist, says the field is 2 to 5 years from routine clinical integration — but validation and insurance coverage remain the critical hurdles.


AI-Powered ECG and Echo Could Shrink 2.5-Year Diagnostic Delay in PH

The Voluntary Sodium Reduction Goals, issued in October 2021, resulted in no significant reduction in sodium content among packaged foods.

FDA-Issued Sodium Targets Ineffective in Reducing Dietary Salt Intake

The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.